These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8420875)

  • 1. Radiotherapy of the R1H-tumor: dose-rate effect on tumor response in brachytherapy with 106-ruthenium eye applicators.
    Kleineidam M; Guthoff R; Schiller F; Chumbley L; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):277-81. PubMed ID: 8420875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of dose rate of ruthenium 106 plaques on tumor regression in the animal model].
    Guthoff R; Kleineidam M; Chumbley L; Schiller F; Beck-Bornholdt HP
    Fortschr Ophthalmol; 1991; 88(6):648-50. PubMed ID: 1794784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined fractionated external beam radiotherapy and low-dose-rate iodine-125 seeds in an experimental tumor system.
    Würschmidt F; Fassbender T; Beck-Bornholdt HP
    Strahlenther Onkol; 2000 Nov; 176(11):524-7. PubMed ID: 11143527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation--126 fractions applied within 6 weeks.
    Beck-Bornholdt HP; Maurer T; Becker S; Omniczynski M; Vogler H; Würschmidt F
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):701-5. PubMed ID: 2921168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-ray brachytherapy with 106Ru plaques for retinoblastoma.
    Schueler AO; Flühs D; Anastassiou G; Jurklies C; Neuhäuser M; Schilling H; Bornfeld N; Sauerwein W
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1212-21. PubMed ID: 16682139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of the rhabdomyosarcoma R1H of the rat: postoperative radiotherapy.
    Carl UM; Beck-Bornholdt HP; Baumann M; Lorenzen J; Vogler H
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):883-6. PubMed ID: 2323976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry of ruthenium-106 ophthalmic applicators with thin layer thermoluminescence dosimeters - Clinical quality control.
    Krause F; Möller M; Risske F; Siebert FA
    Z Med Phys; 2020 May; 30(2):142-147. PubMed ID: 31818650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple experimental technique for interstitial iridium-192 high dose-rate afterloading.
    Milewsky F; Fassbender T; Würschmidt F; Beck-Bornholdt HP
    Strahlenther Onkol; 1990 Sep; 166(9):588-90. PubMed ID: 2218861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-effect relation of interstitial low-dose-rate radiation (Ir192) in an animal tumor model.
    Ruifrok AC; Levendag PC; Lakeman RF; Deurloo IK; Visser AG
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):31-6. PubMed ID: 2298632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106.
    Mossböck G; Rauscher T; Winkler P; Kapp KS; Langmann G
    Strahlenther Onkol; 2007 Oct; 183(10):571-5. PubMed ID: 17896089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dosimetry of ruthenium applicators with an eye phantom and small volume thermoluminescence detectors].
    Muskalla K; Pothmann B; Alberti W; Bornfeld N; Foerster MH; Harder D; Hermann KP; Tabor P; Sack H; Wessing A
    Fortschr Ophthalmol; 1989; 86(6):655-8. PubMed ID: 2625294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The mixed fractionated radiotherapy of R1H tumors in the rat using neutrons and photons].
    Carl UM
    Strahlenther Onkol; 1993 Oct; 169(10):608-11. PubMed ID: 8235985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy of the rhabdomyosarcoma R1H of the rat: the influence of the number of fractions on tumor and skin response.
    Würschmidt F; Vogler H; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 1988 Mar; 14(3):497-502. PubMed ID: 3343156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results and implications of high-resolution surface dosimetry of ruthenium-106 eye applicators.
    Menapace R; Binder W; Chiari A
    Ophthalmologica; 1992; 204(2):93-100. PubMed ID: 1594188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
    Veninga T; Visser AG; van den Berg AP; van Hooije CM; van Geel CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1351-60. PubMed ID: 11286843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ¹⁰⁶Ruthenium plaque therapy (RPT) for retinoblastoma.
    Murakami N; Suzuki S; Ito Y; Yoshimura R; Inaba K; Kuroda Y; Morota M; Mayahara H; Sakudo M; Wakita A; Okamoto H; Sumi M; Kagami Y; Nakagawa K; Ohtomo K; Itami J
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):59-65. PubMed ID: 22575488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of conjunctival epithelial tumors: brachytherapy with ruthenium-106].
    Buc D; Pilon F; Donnarieix D; Kemeny JL; Bacin F; Rigal D
    J Fr Ophtalmol; 2003 Nov; 26(9):929-39. PubMed ID: 14631277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ruthenium 105-applicator for radiation treatment of carcinoma in situ of the cornea and conjunctiva].
    Häberle H; Pham DT; Scholman HJ; Wollensak J
    Ophthalmologe; 1995 Dec; 92(6):866-9. PubMed ID: 8563440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plexiglass replicas for optimizing selection and site of ruthenium 106 applicators].
    Menapace R
    Klin Monbl Augenheilkd; 1990 Jan; 196(1):40-2. PubMed ID: 2313993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy relevant weak sites in industrial quality assurance of 106Ru eye plaques].
    Kaulich TW; Zurheide J; Flühs D; Haug T; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2001 Nov; 177(11):616-23; discussion 624-7. PubMed ID: 11757185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.